321
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gonzalo Barón-Esquivias, Francisco Fernández-Avilés, Felipe Atienza, Pablo Pastor Pueyo, Rocío Toro & Marcelo Sanmartín Fernández. (2015) Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 13:4, pages 341-353.
Read now

Articles from other publishers (4)

Rohan Shah & Manesh R. Patel. (2016) Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice. Therapeutic Advances in Cardiovascular Disease 11:3, pages 105-120.
Crossref
Luís Mont, Francisco Marín, Fernando García-Bragado Dalmau, Marianela Sánchez Martínez & Jaime Gallego Cullere. (2015) Clinical development of rivaroxaban: emerging new clinical evidences?. Future Cardiology 11:5, pages 565-583.
Crossref
Antoni Mart?nez-Rubio & Roger Mart?nez-Torrecilla. (2015) Evidencias actuales de los nuevos anticoagulantes orales en?el?tratamiento de?la?fibrilaci?n auricular no?valvular: comparaci?n de?subestudios. Revista Espa?ola de Cardiolog?a 68:3, pages 185-189.
Crossref
Antoni Mart?nez-Rubio & Roger Mart?nez-Torrecilla. (2015) Current Evidence for New Oral Anticoagulants in the Treatment of Nonvalvular Atrial Fibrillation: Comparison of Substudies. Revista Espa?ola de Cardiolog?a (English Edition) 68:3, pages 185-189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.